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The use of ‘point of care testing’ is emerging as 
an important aspect of general practice care.1 
Assay for C-reactive protein (CRP) is used widely 
in Scandinavian countries and in Switzerland. In 
Norway, a CRP test is now performed in one out 
of 8 consultations, and in a Swedish survey from 
2002, the CRP test was carried out in 41% of all 
patients consulting a general practitioner with an 
airway infection.2 Table 1 outlines the technical and 
economic aspects of point of care testing for CRP. 
In this review we focus on the use of the test in 
common respiratory tract infections.
CRP – what is it?
C-reactive protein is an acute phase protein produced 
in the liver.3,4 Increased production of this protein is 
triggered by cytokines released by infection or tissue 
damage. The CRP molecules bind complement and 
enhance phagocytosis. The serum concentration of 
CRP is usually <3 mg/L, but can increase to 500 mg/L 
within a few days in cases of severe infection. Acute 
cardiovascular events may also induce raised levels 
and much interest has been attached to the proven 
association between slightly elevated CRP values and 
chronic cardiovascular diseases including metabolic 
syndrome.3 A persistent CRP value >3 mg/L is now 
an established risk factor for such diseases. The CRP 
tests used in general practice are not yet suitable 
for assessing cardiovascular risk and can only detect 
CRP concentrations >8 mg/L.5,6 It takes 6–12 hours to 
reach such a level after the start of the inflammatory 
response in infectious diseases. The CRP test is also 
used in diagnosing and monitoring chronic inflammatory 
diseases such as rheumatoid arthritis and inflammatory 
bowel disease.4,7
Respiratory tract infections
There is increasing concern about the overuse of 
antibiotics and increased levels of bacterial resistance.8 
In Australia and in the United Kingdom, approximately 
three-quarters of lower respiratory tract infections are 
treated with antibiotics.9,10 There is strong evidence 
that the majority of respiratory infections are caused 
by viruses.11,12 Antibiotics probably shorten the illness 
in some patients with sinusitis, if the diagnosis has 
been correctly made,13 but are probably of little help in 
patients with acute bronchitis.14 More accurate diagnosis 
of respiratory tract infections is needed, both to avoid 
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inappropriate prescriptions and to identify 
those patients who really need antibiotics.15 
Clinical diagnosis of acute  
bacterial sinusitis 
A diagnosis of bacterial sinusitis should be 
considered when a patient presents with sinus 
or tooth pain, purulent nasal discharge, or 
persistent stuffy nose in connection with a 
flu, common cold, or fever. Physical findings 
that may contribute to a correct diagnosis are 
purulent secretions found in the nasal cavity 
or on the posterior wall of the pharynx.16,17 
Diagnoses of sinusitis made by GPs on the 
basis of symptoms and signs can be confirmed 
in one out of 2 patients when evaluated 
against a computerised tomography scan or 
sinus puncture.16 
Clinical diagnosis of pneumonia
The diagnosis of pneumonia is even more 
diff icult  than that of sinusit is because 
the symptoms of this disease frequently 
resemble that of influenza, acute bronchitis, or 
exacerbation of chronic obstructive pulmonary 
disease (COPD).12 Cough, dyspnoea, chest 
pain and fever are typical symptoms, but in 
the majority of cases in general practice only 
1–2 of these symptoms are present.18,19 Many 
patients thought to have pneumonia have 
normal chest X-rays and many of those with 
normal chest examination have pneumonia on 
chest X-ray.18,19 Percussion can be valuable in 
the rare case of lobar pneumonia.18 Crackles 
are heard in less than 40% of patients with 
pneumonia,18–20 but are also heard in other 
pulmonary conditions. So although their 
presence can support a diagnosis, they are 
often misleading. 
 The clinical picture in pneumonia may 
sometimes be nonspecif ic,  part icular ly 
in the elderly.21 There is a risk of delay in 
diagnosis and treatment which may increase 
the probability of a fatal outcome, at least in 
severe cases.22 
Viral respiratory tract infections
In viral respiratory tract infections the serum 
concentration of CRP usually increases 
and reaches a peak after 2–4 days.23,24 The 
maximum value does not always exceed 8 
mg/L, which is the limit for detection by the 
currently used CRP test, but peaks between 
10–50 mg/L are frequently seen. Higher values 
are often found in influenza and adenoviral 
infections,24,25 but they seldom exceed 100 
mg/L. After the fourth day of illness, the serum 
concentration usually drops rapidly, and will, 
after 10 days, be lower than 10 mg/L if not 
complicated by a bacterial superinfection. The 
examples of CRP responses in uncomplicated 
viral infections in Figure 1 show clearly that 
the interpretation of CRP values is time course 
dependent. 
CRP and bacterial sinusitis
C-reat ive prote in va lues between 10–
50 mg/L are frequently seen in acute 
bacterial sinusitis, but unlike rhinovirus 
infect ions,  where moderate increases 
in CRP last for a few days, values >10 
mg/L may persist after the first week of 
illness. By applying thresholds of 10 and 
25 mg/L respectively, the test contributed to 
improved diagnostic certainty in two studies.17,26 
In bacterial sinusit is, higher values are 
seen when pneumococc i  o r  g roup A 
streptococci are the causative agents.27 It is of 
particular importance to treat such infections 
with antibiotics due to increased tendency 
for complications.
CRP and pneumonia
C-reative protein values >100 mg/L are 
frequently found in pneumonia. In patients 
hospita l ised with community acquired 
pneumonia, mean CRP values on admission 
were 154 and 217 mg/L in two studies.28,29 
The CRP value has been found to be more 
valuable than information about temperature 
and crackles in differentiating pneumonia 
from other respiratory tract infections.19,20,30 
A CRP value >50 mg/L was found four times 
more frequently in patients with pneumonia 
than in patients without pneumonia who had 
been ill for less than a week, and 10 times 
as frequent when comparing patients who 
had been ill for more than a week.30 The low 
frequency of elevated CRP values after 1 week 
in uncomplicated viral infections may explain 
the increased specificity of the test after one 
week of illness (Figure 1). The probability 
of pneumonia increases with increasing 
CRP value due to the increased specificity 
associated with higher thresholds. However, 
one should be aware that high values can 
also be found in myocardial infarction and 
pulmonary embolism.4 The presence of 
pneumonia can usually be ruled out when 
the CRP value is <10 mg/L due to the high 
sensitivity of such a low threshold.20 Caution 
should however, be shown on the first day 
of illness when a delayed rise in CRP may be 
falsely reassuring. 
 Scientific evidence for the usefulness 
of the CRP test in lower respiratory tract 
infections was examined by van der Meer 
et al in a recently published meta-analysis.31 
Although the test was found to be of 
significant diagnostic value in identifying 
patients with pneumonia, the authors did not 
find sufficient support for a wide introduction 
of the CRP test as a guide in the prescription 
of antibiotics. The test’s ability to support or 
question a clinical diagnosis was not dealt with 
in this analysis, neither was it’s usefulness in 
identifying patients with severe pneumonia 
who may need hospital treatment or close 
follow up by the GP.32  
 The test is also useful in detecting severe 
bacterial infections in patients with unclear 
clinical pictures.33 On the other hand, when a 
normal CRP value is found in a patient suffering 
Table 1. Point of care testing for CRP – technical and economical aspects
•   These are finger prick tests using small capillary tubes to collect 5 or 20 µL of blood 
(dependent on device) 
•   Test results are available within 4 minutes and can be used during the consultation 
•   The cost of each test (reagents and other articles of consumption) is $6–8 (a little 
less than is paid to medical laboratories for CRP analysis)
•   The devices used for analyses (which are multipurpose devices) cost $1800–3000 
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severe cough and dyspnoea, exacerbations of 
asthma or COPD may become likely options.12 
However, bacterial exacerbations of COPD are 
often associated with raised CRP levels.34
Evaluation of clinical usefulness 
Although high CRP values may help distinguish 
patients with pneumonia and sinusitis from 
those with acute bronchitis and common 
cold, controlled trials have so far been unable 
to demonstrate improvement in cl inical 
outcome or reduced antibiotic use.7,35,36 In 
these trials, the participating GPs had limited 
prior experience with the test so the results 
should be interpreted cautiously. In contrast, 
two recent but less rigorous studies, have 
shown promising results. In a Norwegian 
study, GPs thought the test contributed to 
the diagnosis in 30% of patients with an 
infectious illness and a reduction in the use 
of antibiotics.37 In a Danish study, GPs who 
used the CRP test were less likely to prescribe 
antibiotics for sinusitis than those who did 
not; 59% compared to 78%, respectively.38 
The prescribing behaviour was significantly 
associated with the CRP level. In a Swedish 
study, 14% of patients with a diagnosis of 
nonspecific respiratory infection were given 
antibiotics when the CRP value was <10 mg/L 
compared to 94% when the CRP value was 
>50 mg/L.2
Concerns about the CRP test
The widespread use of the test in general 
practice in Scandinavian countries has been 
questioned.2,39 It has been stated that the 
CRP test is often used routinely with limited 
impact  on d iagnosis  and t reatment . 39 
Moderately elevated CRP values in patients 
with respiratory tract infections may lead to 
prescriptions of antibiotics that would have 
been avoided if the test had not been carried 
out.2 Research addressing these questions 
should be carried out in order to determine in 
which conditions the test might be beneficial. 
Should the CRP test be introduced in 
Australian general practice?
The often difficult diagnostic and therapeutic 
decisions in respiratory tract infections in 
general practice call for new approaches to 
reduce antibiotic usage without compromising 
patient safety. We still await hard evidence for 
the usefulness of the CRP test in this respect. 
However, convincing predictive values for 
pneumonia have been demonstrated, and our 
understanding of the diagnostic value of the 
CRP test increases steadily with the results 
of new research. The increasing amount 
of evidence lends support to a cautious 
introduction of the test in Australian general 
practice. Updated guidelines for test usage, 
taking into account the clinical picture and 
the duration of illness, would ensure that the 
maximal benefit of the test was obtained.
Summary of important points
• Point of care tests for CRP are widely 
used in general practice in some European 
countries.
• The CRP test has been shown to be 
useful in differentiating pneumonia from 
other respiratory tract infections.
• A high CRP value (>100 mg/L) can indicate 
a severe bacterial infection.
• Antibiotic treatment can usual ly be 
avoided when the CRP value is low (<10 
mg/L).
• The CRP test is only an adjunct to the 
clinical diagnosis. The duration of illness 
must be taken into account.
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Figure 1. Examples of normal CRP values 
according to duration of illness in uncomplicated 
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